Chief Executive Officer

Plasma International Ltd; California (MO); Sur place; USD 400 000 - 660 000; Plein temps

Résumé du poste

Plasma International Ltd. is seeking a Growth-stage medtech Chief Executive Officer to lead scaling efforts and drive enterprise value.

You will oversee cross-functional alignment across clinical, regulatory, manufacturing, and commercial operations, while structuring strategic partnerships and a liquidity-focused plan. The role requires a proven CEO track record in start-ups or early-stage medtech, with a history of revenue growth, partnerships, and value-creating exits.

Qualifications

• Deep experience in implantable or long-term indwelling devices.
• Proven start-up/early-stage CEO experience strongly preferred.
• Track record of scaling revenue in growth-stage medtech.
• Experience structuring third-party commercial agreements.
• Direct involvement in acquisitions or liquidity events.
• Credibility with boards, regulators, and investors.

Responsabilités

• Lead strategic direction and governance for a liquidity-focused exit.
• Establish and scale third-party commercial partnerships.
• Oversee capital-raise activities and investor relations as needed.
• Align clinical, regulatory, manufacturing and commercial operations.
• Position the company for a value-creating liquidity event.
• Build and mentor a high-performance management team.

Connaissances

CEO experience

Medtech growth

Partnerships

Board credibility

Leadership of scientists/engineers

Description du poste

Growth-Stage Medical Device Company | U.S. Market Focus | Defined Exit Horizon

A growth-stage medical device company with FDA-cleared products, active commercial programs, and an advancing internal pipeline is seeking a Chief Executive Officer to lead its next phase of scale and enterprise value creation.

The business operates in clinically significant segments of the implantable and indwelling device market, addressing complications that materially impact patient outcomes, device longevity, and hospital economics.

The Board has defined a clear 24–36 month mandate:

• Establish and scale high-impact third-party commercial partnerships
• Position the company for a successful, value-creating liquidity event

This is a scale-and-position mandate — not an early research proof of concept/development effort.

What You Will Lead

• Additional product development and revenue expansion in defined U.S. medical device markets
• Expansion into selected OUS markets where profitable growth is possible
• Licensing and structuring OEM partnerships with established device manufacturers
• Cross-functional alignment across clinical, regulatory, manufacturing, and commercial operations
• Governance and reporting infrastructure suitable for transaction readiness
• Completion of current capital raise, if necessary
• Structuring and managing an exit/liquidity event under Board guidance

You will inherit a competent, knowledgeable and experienced management team with outstanding grasp of advanced technology, a culture of rapid data-driven decision making, medical device expertise and physician connections, active programs, and a board aligned around growth and exit strategy.

What We Are Looking For

• Deep experience in implantable, disposable, catheter-based, or long-term indwelling medical devices
• Proven start-up / early-stage CEO experience in novel medical technology strongly preferred
• Alternatively, senior divisional leadership with demonstrated readiness for CEO-level accountability coupled with start-up / early-stage company leadership
• Track record of scaling revenue in growth-stage platform medtech businesses
• Demonstrated success structuring and executing third-party commercial agreements where proprietary medical device technology was integrated into a partners product portfolio and delivered measurable revenue impact
• Direct involvement in successful, value-creating acquisitions or liquidity events
• Credibility with boards, investors, regulators, and strategic buyers
• Demonstrated ability to lead a team of highly capable scientists and engineers.

This opportunity requires deep familiarity with the medical device industry and commercial leadership at scale.

Why This Is Different

• FDA-cleared foundation already in place
• Commercialization well underway and revenue growing
• Exciting opportunities for OEM adoption of the technology for application to their existing products, with the prospect of substantial value creation
• Defined time horizon for exit/liquidity event
• Clear board mandate

If you have built value ahead of a liquidity event and want to do it again — deliberately and at pace — we welcome a confidential discussion.